weight loss drugs other than glp-1 Chart: 1 in 8 Americans Now Use for Prescription Weight Loss Medicine: Exploring

DOI: 10.1213/ane.0000000000007764

Foundayo is a small-molecule, non-peptide GLP-1 that offers an oral alternative in a treatment space that has largely been dominated by injectables

In a randomized placebo-controlled trial, participants taking Solnul experienced significant increases in beneficial bacteria, including Akkermansia and Bifidobacterium

Based on human experiments, Holst hypothesized that GLP-1 caused slower emptying of the stomach, which sent a signal through the vagal nerve signifying fullness

While these medications suppress appetite effectively, they can inadvertently lead to insufficient protein consumption, increasing the risk of muscle loss alongside fat reduction

While states typically develop their own utilization management strategies, the model key terms establish standardized coverage criteria (Figure 3)